Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ADMA BIOLOGICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ADMA BIOLOGICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $50.40M came in.
  • Fiscal year ended 2025-12-31: from investing, $21.89M went out.
  • Fiscal year ended 2025-12-31: from financing, $44.02M went out.
  • Fiscal year ended 2025-12-31: change in cash, $15.52M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31$50.40M-$21.89M-$31.94M$2.98M-$15.07M*-$15.52M
2024-12-31$118.67M-$8.57M$0.00$0.00-$58.30M*$51.80M
2023-12-31$8.80M-$4.98M$0.00$0.00-$38.99M*-$35.17M
2022-12-31-$59.51M-$13.91M$64.64M$44.21M*$35.43M
2021-12-31-$112.37M-$13.51M$121.14M-$4.83M
2020-12-31-$102.00M-$12.72M-$13.95M$27.50M$131.20M-$848.64K*$29.17M
2019-12-31-$76.19M-$3.81M-$30.00M$72.50M$48.40M-$10.89M*-$2.72K
2018-12-31-$62.68M-$2.10M$0.00$42.94M-$21.85M
2017-12-31-$37.27M$15.21M$30.00M$39.20M-$8.45M*$38.69M
2016-12-31-$18.27M$904.58K$4.00M$12.90M-$526.09K
2015-12-31-$15.42M-$1.74M$10.26M-$6.76M
2014-12-31-$14.70M-$4.04M$0.00$9.80M*-$8.95M
2013-12-31-$10.89M-$3.13M$27.03M$601.96K*$13.61M
2012-12-31-$6.90M-$118.85K-$150.00K$17.29M$2.33M*$12.45M
2011-12-31-$1.43M-$270.00$0.00$0.00$1.29M*-$141.20K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew debtNew shares soldNot split outChange in cash
2026-06-30$29.54M*-$2.26M*-$25.05M*$35.00K*-$4.40M*
2026-03-31$58.25M$2.40M-$130.19M$588.00K$119.47M*$50.52M
2025-12-31$35.64M*-$276.00K*-$8.90M*$430.00K*
2025-09-30$13.29M*-$14.37M*-$23.04M*$389.00K*-$5.18M*
2025-06-30$21.14M*-$2.53M*$0.00*$2.06M*
2025-03-31-$19.68M-$4.72M$0.00$101.00K-$7.23M*-$31.52M
2024-12-31$50.22M*-$2.75M*$0.00*$443.00K*-$31.47M*
2024-09-30$25.03M*-$1.10M*$5.69M*-$31.16M*
2024-06-30$45.65M*-$2.37M*$331.00K*
2024-03-31-$2.22M-$2.36M$1.03M-$2.48M*-$6.03M
2023-12-31$17.60M*-$1.41M*$8.00K*-$39.00M*
2023-09-30$11.98M*-$757.00K*$624.00K*
2023-06-30-$6.06M*-$872.00K*$472.00K*
2023-03-31-$14.72M-$1.95M$0.00-$650.00K*-$17.32M
2022-12-31-$7.38M*-$3.75M*$64.64M*-$1.90M*
2022-09-30-$13.28M*-$3.38M*$0.00*-$843.79K*
2022-06-30-$12.83M*-$3.94M*$0.00*
2022-03-31-$26.01M-$2.84M$0.00$47.27M*$18.42M
2021-12-31-$33.47M*-$3.68M*$53.83M*
2021-09-30-$13.41M*-$2.79M*$8.21M*
2021-06-30-$32.26M*-$4.48M*$17.19M*
2021-03-31-$33.23M-$2.57M$0.00$41.91M$6.04M
2020-12-31-$32.22M*-$3.60M*$15.00M*$31.85M*-$3.75M*
2020-09-30-$23.85M*-$2.89M*$0.00*$10.64M*-$16.11M*
2020-06-30-$21.28M*-$4.17M*$0.00*$0.00*-$25.45M*
2020-03-31-$24.65M-$2.07M$12.50M$88.70M$74.48M
2019-12-31-$19.65M*-$1.59M*$0.00*$0.00*-$21.25M*
2019-09-30-$23.63M*-$1.97M*$0.00*$0.00*-$25.61M*
2019-06-30-$18.62M*-$135.22K*$27.50M*$48.40M*$57.08M*
2019-03-31-$14.29M-$110.45K$45.00M$0.00-$40.82M*-$10.22M
2018-12-31-$18.79M*-$819.01K*$0.00*$0.00*-$19.61M*
2018-09-30-$12.54M*-$230.22K*$0.00*-$1.28K*-$12.79M*
2018-06-30-$14.91M*-$497.13K*$0.00*$42.94M*$27.53M*
2018-03-31-$16.43M-$549.25K$0.00-$16.99M
2017-12-31-$13.36M*-$2.01M*$30.00M*$39.20M*-$18.83M*$35.01M*
2017-09-30-$9.74M*-$569.90K*$0.00*$0.00*-$1.66M*-$11.97M*
2017-06-30-$8.78M*$12.65M*$13.15M*$17.03M*
2017-03-31-$5.40M$5.14M-$1.12M*-$1.37M
2016-12-31-$3.61M*$5.63M*$0.00*$0.00*$2.01M*
2016-09-30-$4.68M*$238.92K*$0.00*-$172.20K*-$4.64M*
2016-06-30-$4.80M*-$8.62M*$13.07M*$3.97M*$3.62M*
2016-03-31-$5.17M$3.66M$0.00-$1.52M
2015-12-31-$4.08M*$5.40M*$0.00*$1.26M*
2015-09-30-$2.67M*$4.16M*-$136.00K*$1.36M*
2015-06-30-$4.45M*-$4.43M*-$69.62K*-$8.74M*
2015-03-31-$4.22M-$6.87M$10.46M-$634.84K
2014-12-31-$2.90M*$1.11M*$0.00*$5.04M*$3.25M*
2014-09-30-$2.47M*-$1.40M*$0.00*-$3.92M*
2014-06-30-$4.30M*-$4.37M*$0.00*-$8.65M*
2014-03-31-$5.04M$620.20K$0.00$4.79M*$368.48K
2013-12-31-$2.96M*-$2.94M*$26.67M*$20.77M*
2013-09-30-$2.23M*-$16.37K*-$2.27M*
2013-06-30-$2.63M*-$108.73K*-$2.67M*
2013-03-31-$3.07M-$66.07K$0.00$925.69K*-$2.22M
2012-12-31-$1.81M*-$35.33K*$0.00*$3.66M*$1.82M*
2012-09-30-$2.05M*-$27.37K*$0.00*-$2.12M*
2012-06-30-$1.04M*-$56.15K*$0.00*-$1.40M*
2012-03-31-$2.00M$0.00$17.29M-$1.14M*$14.15M
2011-12-31-$12.83K*-$270.00*$0.00*$2.17K*
2011-09-30-$5.18K-$2.60K
2011-06-30-$540.84K*$547.59K*$6.75K*
2011-03-31-$445.12K$0.00$0.00-$147.47K
2010-12-31-$9.02K*-$519.00*
2010-09-30-$8.39K-$8.39K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43